Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 66 entries
Sorted by: Best Match Show Resources per page
Auxin gradient along the root of the maize seedling.

Planta

Martin HV, Elliott MC, Wangermann E, Pilet PE.
PMID: 24414774
Planta. 1978 Jan;141(2):179-81. doi: 10.1007/BF00387886.

[5-(3)H]Indol-3yl-acetic acid (IAA) applied to the shoot apices of intact 6-day-old maize (Zea mays L.) plants moved into the primary root and accumulated at the root apex. IAA from the shoot could partially satisfy the requirement of the primary...

Cite
Martin HV, Elliott MC, Wangermann E, et al. Auxin gradient along the root of the maize seedling. Planta. 1978;141(2):179-81doi: 10.1007/BF00387886.
Martin, H. V., Elliott, M. C., Wangermann, E., & Pilet, P. E. (1978). Auxin gradient along the root of the maize seedling. Planta, 141(2), 179-81. https://doi.org/10.1007/BF00387886
Martin, H V, et al. "Auxin gradient along the root of the maize seedling." Planta vol. 141,2 (1978): 179-81. doi: https://doi.org/10.1007/BF00387886
Martin HV, Elliott MC, Wangermann E, Pilet PE. Auxin gradient along the root of the maize seedling. Planta. 1978 Jan;141(2):179-81. doi: 10.1007/BF00387886. PMID: 24414774.
Copy Download .nbib Format: NLM
The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET.

Cellular logistics

Lachmann J, Glaubke E, Moore PS, Ungermann C.
PMID: 25750764
Cell Logist. 2014 Oct 02;4(4):e970840. doi: 10.4161/21592780.2014.970840. eCollection 2014.

Membrane fusion in the endocytic pathway is mediated by a protein machinery consistent of Rab GTPases, tethering factors and SNAREs. In yeast, the endosomal CORVET and lysosomal HOPS tethering complexes share 4 of their 6 subunits. The 2 additional...

Cite
Lachmann J, Glaubke E, Moore PS, et al. The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET. Cell Logist. 2014;4(4):e970840doi: 10.4161/21592780.2014.970840.
Lachmann, J., Glaubke, E., Moore, P. S., & Ungermann, C. (2014). The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET. Cellular logistics, 4(4), e970840. https://doi.org/10.4161/21592780.2014.970840
Lachmann, Jens, et al. "The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET." Cellular logistics vol. 4,4 (2014): e970840. doi: https://doi.org/10.4161/21592780.2014.970840
Lachmann J, Glaubke E, Moore PS, Ungermann C. The Vps39-like TRAP1 is an effector of Rab5 and likely the missing Vps3 subunit of human CORVET. Cell Logist. 2014 Oct 02;4(4):e970840. doi: 10.4161/21592780.2014.970840. eCollection 2014. PMID: 25750764; PMCID: PMC4325178.
Copy Download .nbib Format: NLM
Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry.

PloS one

Viollet L, Glusman G, Murphy KJ, Newcomb TM, Reyna SP, Sweney M, Nelson B, Andermann F, Andermann E, Acsadi G, Barbano RL, Brown C, Brunkow ME, Chugani HT, Cheyette SR, Collins A, DeBrosse SD, Galas D, Friedman J, Hood L, Huff C, Jorde LB, King MD, LaSalle B, Leventer RJ, Lewelt AJ, Massart MB, Mérida MR, Ptáček LJ, Roach JC, Rust RS, Renault F, Sanger TD, Sotero de Menezes MA, Tennyson R, Uldall P, Zhang Y, Zupanc M, Xin W, Silver K, Swoboda KJ.
PMID: 26322789
PLoS One. 2015 Aug 31;10(8):e0137370. doi: 10.1371/journal.pone.0137370. eCollection 2015.

No abstract available.

Cite
Viollet L, Glusman G, Murphy KJ, et al. Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PLoS One. 2015;10(8):e0137370doi: 10.1371/journal.pone.0137370.
Viollet, L., Glusman, G., Murphy, K. J., Newcomb, T. M., Reyna, S. P., Sweney, M., Nelson, B., Andermann, F., Andermann, E., Acsadi, G., Barbano, R. L., Brown, C., Brunkow, M. E., Chugani, H. T., Cheyette, S. R., Collins, A., DeBrosse, S. D., Galas, D., Friedman, J., Hood, L., Huff, C., Jorde, L. B., King, M. D., LaSalle, B., Leventer, R. J., Lewelt, A. J., Massart, M. B., Mérida, M. R., Ptáček, L. J., Roach, J. C., Rust, R. S., Renault, F., Sanger, T. D., Sotero de Menezes, M. A., Tennyson, R., Uldall, P., Zhang, Y., Zupanc, M., Xin, W., Silver, K., & Swoboda, K. J. (2015). Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PloS one, 10(8), e0137370. https://doi.org/10.1371/journal.pone.0137370
Viollet, Louis, et al. "Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry." PloS one vol. 10,8 (2015): e0137370. doi: https://doi.org/10.1371/journal.pone.0137370
Viollet L, Glusman G, Murphy KJ, Newcomb TM, Reyna SP, Sweney M, Nelson B, Andermann F, Andermann E, Acsadi G, Barbano RL, Brown C, Brunkow ME, Chugani HT, Cheyette SR, Collins A, DeBrosse SD, Galas D, Friedman J, Hood L, Huff C, Jorde LB, King MD, LaSalle B, Leventer RJ, Lewelt AJ, Massart MB, Mérida MR, Ptáček LJ, Roach JC, Rust RS, Renault F, Sanger TD, Sotero de Menezes MA, Tennyson R, Uldall P, Zhang Y, Zupanc M, Xin W, Silver K, Swoboda KJ. Correction: Alternating Hemiplegia of Childhood: Retrospective Genetic Study and Genotype-Phenotype Correlations in 187 Subjects from the US AHCF Registry. PLoS One. 2015 Aug 31;10(8):e0137370. doi: 10.1371/journal.pone.0137370. eCollection 2015. PMID: 26322789; PMCID: PMC4554723.
Copy Download .nbib Format: NLM
Rab GTPases and tethering in the yeast endocytic pathway.

Small GTPases

Lachmann J, Ungermann C, Engelbrecht-Vandré S.
PMID: 21776422
Small GTPases. 2011 May;2(3):182-186. doi: 10.4161/sgtp.2.3.16701.

Within eukaryotic cells, Rab GTPases control the maturation of early to late endosomes and their subsequent fusion with the vacuole. Within this ExtraView, we will focus on our recent findings regarding the activation of the Rab7 homolog Ypt7 in...

Cite
Lachmann J, Ungermann C, Engelbrecht-Vandré S. Rab GTPases and tethering in the yeast endocytic pathway. Small GTPases. 2011;2(3):182-186doi: 10.4161/sgtp.2.3.16701.
Lachmann, J., Ungermann, C., & Engelbrecht-Vandré, S. (2011). Rab GTPases and tethering in the yeast endocytic pathway. Small GTPases, 2(3), 182-186. https://doi.org/10.4161/sgtp.2.3.16701
Lachmann, Jens, et al. "Rab GTPases and tethering in the yeast endocytic pathway." Small GTPases vol. 2,3 (2011): 182-186. doi: https://doi.org/10.4161/sgtp.2.3.16701
Lachmann J, Ungermann C, Engelbrecht-Vandré S. Rab GTPases and tethering in the yeast endocytic pathway. Small GTPases. 2011 May;2(3):182-186. doi: 10.4161/sgtp.2.3.16701. PMID: 21776422; PMCID: PMC3136951.
Copy Download .nbib Format: NLM
Tracking of the dynamic localization of the Rab-specific HOPS subunits reveal their distinct interaction with Ypt7 and vacuoles.

Cellular logistics

Auffarth K, Arlt H, Lachmann J, Cabrera M, Ungermann C.
PMID: 25210650
Cell Logist. 2014 May 12;4:e29191. doi: 10.4161/cl.29191. eCollection 2014.

Endosomal and vacuole fusion depends on the two homologous tethering complexes CORVET and HOPS. HOPS binds the activated Rab GTPase Ypt7 via two distinct subunits, Vps39 and Vps41. To understand the participation and possible polarity of Vps41 and Vps39...

Cite
Auffarth K, Arlt H, Lachmann J, et al. Tracking of the dynamic localization of the Rab-specific HOPS subunits reveal their distinct interaction with Ypt7 and vacuoles. Cell Logist. 2014;4:e29191doi: 10.4161/cl.29191.
Auffarth, K., Arlt, H., Lachmann, J., Cabrera, M., & Ungermann, C. (2014). Tracking of the dynamic localization of the Rab-specific HOPS subunits reveal their distinct interaction with Ypt7 and vacuoles. Cellular logistics, 4e29191. https://doi.org/10.4161/cl.29191
Auffarth, Kathrin, et al. "Tracking of the dynamic localization of the Rab-specific HOPS subunits reveal their distinct interaction with Ypt7 and vacuoles." Cellular logistics vol. 4 (2014): e29191. doi: https://doi.org/10.4161/cl.29191
Auffarth K, Arlt H, Lachmann J, Cabrera M, Ungermann C. Tracking of the dynamic localization of the Rab-specific HOPS subunits reveal their distinct interaction with Ypt7 and vacuoles. Cell Logist. 2014 May 12;4:e29191. doi: 10.4161/cl.29191. eCollection 2014. PMID: 25210650; PMCID: PMC4156483.
Copy Download .nbib Format: NLM
The Comprehensive Heart Failure Centre in Würzburg, Germany.

European heart journal

Angermann CE, Frantz S, Maack C.
PMID: 29788301
Eur Heart J. 2018 May 21;39(20):1757-1760. doi: 10.1093/eurheartj/ehy202.

No abstract available.

Cite
Angermann CE, Frantz S, Maack C. The Comprehensive Heart Failure Centre in Würzburg, Germany. Eur Heart J. 2018;39(20):1757-1760doi: 10.1093/eurheartj/ehy202.
Angermann, C. E., Frantz, S., & Maack, C. (2018). The Comprehensive Heart Failure Centre in Würzburg, Germany. European heart journal, 39(20), 1757-1760. https://doi.org/10.1093/eurheartj/ehy202
Angermann, Christiane E, et al. "The Comprehensive Heart Failure Centre in Würzburg, Germany." European heart journal vol. 39,20 (2018): 1757-1760. doi: https://doi.org/10.1093/eurheartj/ehy202
Angermann CE, Frantz S, Maack C. The Comprehensive Heart Failure Centre in Würzburg, Germany. Eur Heart J. 2018 May 21;39(20):1757-1760. doi: 10.1093/eurheartj/ehy202. PMID: 29788301.
Copy Download .nbib Format: NLM
Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure.

Journal of cardiac failure

Sahiti F, Morbach C, Henneges C, Stefenelli U, Scholz N, Cejka V, Albert J, Heuschmann PU, Ertl G, Frantz S, Angermann CE, Störk S.
PMID: 34332057
J Card Fail. 2021 Dec;27(12):1393-1403. doi: 10.1016/j.cardfail.2021.07.004. Epub 2021 Jul 29.

BACKGROUND: The left ventricular ejection fraction (LVEF) is the most commonly used measure describing pumping efficiency, but it is heavily dependent on loading conditions and therefore not well-suited to study pathophysiologic changes. The novel concept of echocardiography-derived myocardial work...

Cite
Sahiti F, Morbach C, Henneges C, et al. Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. J Card Fail. 2021;27(12):1393-1403doi: 10.1016/j.cardfail.2021.07.004.
Sahiti, F., Morbach, C., Henneges, C., Stefenelli, U., Scholz, N., Cejka, V., Albert, J., Heuschmann, P. U., Ertl, G., Frantz, S., Angermann, C. E., & Störk, S. (2021). Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. Journal of cardiac failure, 27(12), 1393-1403. https://doi.org/10.1016/j.cardfail.2021.07.004
Sahiti, Floran, et al. "Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure." Journal of cardiac failure vol. 27,12 (2021): 1393-1403. doi: https://doi.org/10.1016/j.cardfail.2021.07.004
Sahiti F, Morbach C, Henneges C, Stefenelli U, Scholz N, Cejka V, Albert J, Heuschmann PU, Ertl G, Frantz S, Angermann CE, Störk S. Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. J Card Fail. 2021 Dec;27(12):1393-1403. doi: 10.1016/j.cardfail.2021.07.004. Epub 2021 Jul 29. PMID: 34332057.
Copy Download .nbib Format: NLM
A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy.

RNA biology

Martens L, Rühle F, Witten A, Meder B, Katus HA, Arbustini E, Hasenfuß G, Sinner MF, Kääb S, Pankuweit S, Angermann C, Bornberg-Bauer E, Stoll M.
PMID: 34313541
RNA Biol. 2021 Oct 15;18:409-415. doi: 10.1080/15476286.2021.1952756. Epub 2021 Jul 27.

lncRNAs are at the core of many regulatory processes and have also been recognized to be involved in various complex diseases. They affect gene regulation through direct interactions with RNA, DNA or proteins. Accordingly, lncRNA structure is likely to...

Cite
Martens L, Rühle F, Witten A, et al. A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. RNA Biol. 2021;18:409-415doi: 10.1080/15476286.2021.1952756.
Martens, L., Rühle, F., Witten, A., Meder, B., Katus, H. A., Arbustini, E., Hasenfuß, G., Sinner, M. F., Kääb, S., Pankuweit, S., Angermann, C., Bornberg-Bauer, E., & Stoll, M. (2021). A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. RNA biology, 18409-415. https://doi.org/10.1080/15476286.2021.1952756
Martens, Leonie, et al. "A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy." RNA biology vol. 18 (2021): 409-415. doi: https://doi.org/10.1080/15476286.2021.1952756
Martens L, Rühle F, Witten A, Meder B, Katus HA, Arbustini E, Hasenfuß G, Sinner MF, Kääb S, Pankuweit S, Angermann C, Bornberg-Bauer E, Stoll M. A genetic variant alters the secondary structure of the lncRNA H19 and is associated with dilated cardiomyopathy. RNA Biol. 2021 Oct 15;18:409-415. doi: 10.1080/15476286.2021.1952756. Epub 2021 Jul 27. PMID: 34313541.
Copy Download .nbib Format: NLM
Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease.

European heart journal

, Sammons E, Hopewell JC, Chen F, Stevens W, Wallendszus K, Valdes-Marquez E, Dayanandan R, Knott C, Murphy K, Wincott E, Baxter A, Goodenough R, Lay M, Hill M, Macdonnell S, Fabbri G, Lucci D, Fajardo-Moser M, Brenner S, Hao D, Zhang H, Liu J, Wuhan B, Mosegaard S, Herrington W, Wanner C, Angermann C, Ertl G, Maggioni A, Barter P, Mihaylova B, Mitchel Y, Blaustein R, Goto S, Tobert J, DeLucca P, Chen Y, Chen Z, Gray A, Haynes R, Armitage J, Baigent C, Wiviott S, Cannon C, Braunwald E, Collins R, Bowman L, Landray M.
PMID: 34910136
Eur Heart J. 2021 Dec 15; doi: 10.1093/eurheartj/ehab863. Epub 2021 Dec 15.

AIMS: REVEAL was the first randomized controlled trial to demonstrate that adding cholesteryl ester transfer protein inhibitor therapy to intensive statin therapy reduced the risk of major coronary events. We now report results from extended follow-up beyond the scheduled...

Cite
, Sammons E, Hopewell JC, et al. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab863.
, Sammons, E., Hopewell, J. C., Chen, F., Stevens, W., Wallendszus, K., Valdes-Marquez, E., Dayanandan, R., Knott, C., Murphy, K., Wincott, E., Baxter, A., Goodenough, R., Lay, M., Hill, M., Macdonnell, S., Fabbri, G., Lucci, D., Fajardo-Moser, M., Brenner, S., Hao, D., Zhang, H., Liu, J., Wuhan, B., Mosegaard, S., Herrington, W., Wanner, C., Angermann, C., Ertl, G., Maggioni, A., Barter, P., Mihaylova, B., Mitchel, Y., Blaustein, R., Goto, S., Tobert, J., DeLucca, P., Chen, Y., Chen, Z., Gray, A., Haynes, R., Armitage, J., Baigent, C., Wiviott, S., Cannon, C., Braunwald, E., Collins, R., Bowman, L., Landray, M. (2021). Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. European heart journal, . https://doi.org/10.1093/eurheartj/ehab863
, et al. "Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab863
, Sammons E, Hopewell JC, Chen F, Stevens W, Wallendszus K, Valdes-Marquez E, Dayanandan R, Knott C, Murphy K, Wincott E, Baxter A, Goodenough R, Lay M, Hill M, Macdonnell S, Fabbri G, Lucci D, Fajardo-Moser M, Brenner S, Hao D, Zhang H, Liu J, Wuhan B, Mosegaard S, Herrington W, Wanner C, Angermann C, Ertl G, Maggioni A, Barter P, Mihaylova B, Mitchel Y, Blaustein R, Goto S, Tobert J, DeLucca P, Chen Y, Chen Z, Gray A, Haynes R, Armitage J, Baigent C, Wiviott S, Cannon C, Braunwald E, Collins R, Bowman L, Landray M. Long-term safety and efficacy of anacetrapib in patients with atherosclerotic vascular disease. Eur Heart J. 2021 Dec 15; doi: 10.1093/eurheartj/ehab863. Epub 2021 Dec 15. PMID: 34910136.
Copy Download .nbib Format: NLM
Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure.

Journal of cardiac failure

Sahiti F, Morbach C, Henneges C, Stefenelli U, Scholz N, Cejka V, Albert J, Heuschmann PU, Ertl G, Frantz S, Angermann CE, Störk S.
PMID: 34332057
J Card Fail. 2021 Dec;27(12):1393-1403. doi: 10.1016/j.cardfail.2021.07.004. Epub 2021 Jul 29.

BACKGROUND: The left ventricular ejection fraction (LVEF) is the most commonly used measure describing pumping efficiency, but it is heavily dependent on loading conditions and therefore not well-suited to study pathophysiologic changes. The novel concept of echocardiography-derived myocardial work...

Cite
Sahiti F, Morbach C, Henneges C, et al. Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. J Card Fail. 2021;27(12):1393-1403doi: 10.1016/j.cardfail.2021.07.004.
Sahiti, F., Morbach, C., Henneges, C., Stefenelli, U., Scholz, N., Cejka, V., Albert, J., Heuschmann, P. U., Ertl, G., Frantz, S., Angermann, C. E., & Störk, S. (2021). Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. Journal of cardiac failure, 27(12), 1393-1403. https://doi.org/10.1016/j.cardfail.2021.07.004
Sahiti, Floran, et al. "Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure." Journal of cardiac failure vol. 27,12 (2021): 1393-1403. doi: https://doi.org/10.1016/j.cardfail.2021.07.004
Sahiti F, Morbach C, Henneges C, Stefenelli U, Scholz N, Cejka V, Albert J, Heuschmann PU, Ertl G, Frantz S, Angermann CE, Störk S. Dynamics of Left Ventricular Myocardial Work in Patients Hospitalized for Acute Heart Failure. J Card Fail. 2021 Dec;27(12):1393-1403. doi: 10.1016/j.cardfail.2021.07.004. Epub 2021 Jul 29. PMID: 34332057.
Copy Download .nbib Format: NLM
Characterization of wet-chemically treated silicon interfaces by surface photovoltage measurements.

Analytical and bioanalytical chemistry

Angermann H.
PMID: 12397491
Anal Bioanal Chem. 2002 Oct;374(4):676-80. doi: 10.1007/s00216-002-1450-4. Epub 2002 Aug 28.

A non-destructive and surface-sensitive surface photovoltage (SPV) technique was employed to investigate the influence of important wet-chemical treatments on the electronic surface properties. The preparation-induced surface roughness as well as the hydrogen and oxide coverage were additionally determined by...

Cite
Angermann H. Characterization of wet-chemically treated silicon interfaces by surface photovoltage measurements. Anal Bioanal Chem. 2002;374(4):676-80doi: 10.1007/s00216-002-1450-4.
Angermann, H. (2002). Characterization of wet-chemically treated silicon interfaces by surface photovoltage measurements. Analytical and bioanalytical chemistry, 374(4), 676-80. https://doi.org/10.1007/s00216-002-1450-4
Angermann, H. "Characterization of wet-chemically treated silicon interfaces by surface photovoltage measurements." Analytical and bioanalytical chemistry vol. 374,4 (2002): 676-80. doi: https://doi.org/10.1007/s00216-002-1450-4
Angermann H. Characterization of wet-chemically treated silicon interfaces by surface photovoltage measurements. Anal Bioanal Chem. 2002 Oct;374(4):676-80. doi: 10.1007/s00216-002-1450-4. Epub 2002 Aug 28. PMID: 12397491.
Copy Download .nbib Format: NLM
Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration.

Journal of ophthalmology

Huber AL, Angermann R, Nowosielski Y, Seifarth C, Kralinger MT, Zehetner C.
PMID: 34956670
J Ophthalmol. 2021 Dec 15;2021:7058505. doi: 10.1155/2021/7058505. eCollection 2021.

PURPOSE: To analyze the effect of intravitreal aflibercept injections on systemic levels of insulin-like growth factor-1 and vascular endothelial growth factor-A in patients with diabetic retinopathy and age-related macular degeneration.METHODS: Vascular endothelial growth factor-A and insulin-like growth factor-1 levels...

Cite
Huber AL, Angermann R, Nowosielski Y, et al. Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. J Ophthalmol. 2021;2021:7058505doi: 10.1155/2021/7058505.
Huber, A. L., Angermann, R., Nowosielski, Y., Seifarth, C., Kralinger, M. T., & Zehetner, C. (2021). Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. Journal of ophthalmology, 20217058505. https://doi.org/10.1155/2021/7058505
Huber, Anna Lena, et al. "Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration." Journal of ophthalmology vol. 2021 (2021): 7058505. doi: https://doi.org/10.1155/2021/7058505
Huber AL, Angermann R, Nowosielski Y, Seifarth C, Kralinger MT, Zehetner C. Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration. J Ophthalmol. 2021 Dec 15;2021:7058505. doi: 10.1155/2021/7058505. eCollection 2021. PMID: 34956670; PMCID: PMC8694974.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 66 entries